SlideShare uma empresa Scribd logo
Patient’s Journey using RealWorld
Data and itsAdvancedAnalytics
Kevin Lee
Disclaimer
The views and opinions presented here represent those of the
speaker and should not be considered to represent any
companies or organizations.
• What is RWD?
• Why is it important?
• Patient’s Journey using RWD
• Examples of Insights from RWD
• Challenges in RWD
• Technology requirements of
RWD
• Conclusion
4
What is Real Word Data (RWD)?
Data collected outside of Clinical Trial Study
Real World Data
Clinical Trial
Data
5
The
Examples
of Real
Word Data
(RWD)
RWD
Electronic
Health Records
(EHR) (e.g.,
Optum Market
Clarity Data)
Claim Activities
(e.g., IQVIA
LAAD, NPA,
Xponent, LRx)
Billing Activities
(e.g., Insurance
Payer data)
Patient Registry
6
Real World Data vs Clinical Trial Data
Real World Data Clinical Trial Data
Population All the population Population of Eligible Criteria
Patients Number ~100 million 300 to 3,000 volunteers in Phase 3
Bias Various bias Minimized bias
Environment Real World Controlled
Visit Any Visit Scheduled Visit
Purpose Effectiveness Efficacy
Treatment Schedule As needed Fixed
Comparison All the drugs Placebo / Control
Patient Monitor As needed Continuous during Clinical Trial
Data Quality As they come Cleaned
Data Collection Various sources (e.g., EHR, Claims) EDC per protocol
Data Format Any format SAS dataset format
Data Structure Any data structure Tabular data structure
7
Why is RWD important? • More comprehensive, holistic
patient journey history
• More Personalized medicine
• Safety and Efficacy findings in
bigger population
• More complete pictures on how
medicines are used in the real world
rather than controlled environment
in Clinical Trial
• Leading to better clinical trial design
(e.g., Patient recruitment, other
indication )
• Helping drug companies to manage
product life cycle (pre-launch, post-
launch, during patent, after patent)
• Helping drug companies for
marketing and sales strategies
8
Patient 1001
got AC1 LAB
test on 2020-
01-15.
Patient
1001 started
“Metformin
” on 2020-
01-25.
Patient 1001
was diagnosed
with
‘prediabetes’
on 2020-01-22.
Patient 1001
got AC1 LAB
test on 2021-
01-10.
Patient 1001
was diagnosed
with ‘Diabetes,
Type 2’ on
2021-01-20.
Patient 1001
switched to
“Jardiance 10 mg”
on 2021-01-23.
Patient 1001
got AC1 LAB
test on 2021-
06-14.
Patient 1001
switched to
“Jardiance 25 mg”
on 2021-06-20.
Patient 1001 visited his family doctor.
Patient 1001 used “Aetna” insurance
Patient 1001
complained
about
“Dizziness”.
Patient 1001
got AC1 lab
result at 6.2%
on 2020-01-21
Patient 1001
got AC1 lab
result at 7.1%
on 2021-01-18
Patient 1001
got AC1 lab
result at 8.0%
on 2021-06-18
Patient 1001
got AC1 LAB
test on 2022-
01-14.
Patient 1001
got AC1 lab
result at 7.0%
on 2022-01-18
Patient’s Journey in RWD
9
Data in RWD Patient’s Journey
Real World Data
(RWD)
Patient
Demograp
hics
Diagnosis
Procedures
Claims
Healthcare
Provider
Insurance
Payers
AE
LAB
Vital
• EHR
• Patient’s Medical
Activity based
• Demo, Vitals, Lab,
AE, provider’s notes
• Claims
• Patient’s Claim
Activity based
• Prescriptions,
Diagnosis,
Procedures
• Source
• Providers
• Payers
10
Examples of insights from RWD (1)
Clinical Trial Optimization
• Originally, Jardiance is approved for Type 2 Diabetes treatment, but in RWD, it
has been prescribed for pre-diabetes patients.
• Using RWD, Statisticians / programmers has found Jardiance show positive
effectiveness with low safety issues.
• Using RWD, Statisticians / programmers could compare effectiveness
compared to competitors.
• Using RWD, Statisticians / programmers could find safety information of
medicines.
• Using RWD, Patients recruitments are more effective.
11
Sales Performance Metrics
• Geographic Sales
Performance
• Sales Performance vs
Forecasts
• Sales Comparison with
Competitors ( e.g., 50%
market share for
Jardiance)
• Sales Performance by
quarters or month
• Source of Business
• New
• Switch
• Continued
Examples of insights from RWD (2)
12
Sales Performance Metrics
GeographicSales Performance
Sales Performance vs Forecasts
Sales Comparison with Competitors
Sales Performance by quarters
Source of Business
New
Switch
Continued
Examples of insights from RWD (3)
Treatment Effectiveness /
Personalized Medicine
• 1st Line vs 2nd Line
• Combo and Mono
Therapy
• Patient Profile – Age,
Gender, Races,
Diagnosis
13
Challenge in RWD
• Quality of data
• As they come, not cleaned /
validated
• High possibility of Bias
• Various data sources (e.g., Veeva
CRM, IQVIA Claim, Hospital Data)
• Unstructured / Unstandardized Data
• Big Data
• Data integration / ETL
• System Infrastructure for RWD –
Data Storage, Data Processing,
Analysis
• Return of Investment
• Usage in Clinical Trials
• Regulatory restriction
Technologies in
RWD
RWD is Big
Data
• It contains up to 5 years of ~100 million patient’s records per TA.
• ~1 trillion claims for Diagnosis, Procedure & Prescription.
• Typical Analysis for RWD contain up to ~1 trillion records.
• Tools : Cloud Computing
RWD in Cloud
Computing
• Big Data in RWD requires much bigger computing power, which fits
well with Cloud Computing.
• Flexible and scalable Cloud Computing environment will serve RWD
Advanced Analytics (e.g. AI, prediction, Data Visualization) well.
• An easy access for the reports and analysis thru internet connection.
• A great collaboration environment / platform for research and analysis.
• Tools : AWS, Azure, Databricks
RWD in Central Database /
Data Warehouse
17
• Tool to store, manage and govern RWD Data
• Security and Data Quality for Sensitive health care data
• Data Share and Access to different stakeholders
• Centralized data storage
• Tool : AWS Redshift, Snowflake, Oracle, Hive
RWD in Open-Source
Programming
• RWD is not a regulatory required data.
• Open-source programming for advanced analytics (e.g.
Machine Learning, Data Visualization)
• More and more organizations are expanding to open-
source programming for RWD analysis for operating cost
and advanced analysis.
• Tool : R, Python, SQL, R-Shiny
RWD in
Data
Visualization
• Monthly and weekly
performance metrics of the
products in market
• Interactive dashboard
implementation by filters
and graphs
• Patients Journey from
Diagnosis, EHR, to
Prescriptions
• Tool : Tableau, Power BI
19
RWD in Machine Learning/
Prediction
20
• Predicting the treatment effectiveness
• Clinical Trial Optimization on Study Design, Patients recruitments
• Drug Discovery on identifying potential drug targets
• Predicting personalized Medicine for patients
• Structured data from unstructured data ( e.g., Insights from
doctors’ notes)
• Tools : Jupyter, R Studio, Databricks, Machine Learning, Deep
Learning, Natural Language Procession, Convolutional Neural
Network
21
Conclusion
• Real World Data could provide valuable medical and business(commercial)
insight and understanding in Real World Situation.
• RWD could bring comprehensive, holistic real world patient’s journey history
(e.g., up to 5 years or more ), leading to Personalized Medicine.
• RWD could support drug pipelines (e.g., clinical trials) and commercial drug
management (e.g., marketing and sales).
• More and more RWD will be integrated with Biometric function.
• RWD need technology investment (e.g., Big Data, Cloud Computing, Open-
Source, Machine Learning) to fully utilize its potential and benefits.
Any Questions?

Mais conteúdo relacionado

Semelhante a Patient’s Journey using Real World Data and its Advanced Analytics

Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...
Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...
Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...
Wellbe
 
Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...
Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...
Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...
ProRelix Research
 
McGrath Health Data Analyst SXSW
McGrath Health Data Analyst SXSWMcGrath Health Data Analyst SXSW
McGrath Health Data Analyst SXSW
Robert McGrath
 

Semelhante a Patient’s Journey using Real World Data and its Advanced Analytics (20)

Accelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World EvidenceAccelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World Evidence
 
Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?
 
e-MDs Summary Overview
e-MDs Summary Overviewe-MDs Summary Overview
e-MDs Summary Overview
 
QlikView For Healthcare From Top Line Strategies
QlikView For Healthcare From Top Line StrategiesQlikView For Healthcare From Top Line Strategies
QlikView For Healthcare From Top Line Strategies
 
OpenERP Health & Hospital Management System
OpenERP Health & Hospital Management SystemOpenERP Health & Hospital Management System
OpenERP Health & Hospital Management System
 
Real world evidence pharmaceutical industry-pl
Real world evidence pharmaceutical industry-plReal world evidence pharmaceutical industry-pl
Real world evidence pharmaceutical industry-pl
 
Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...
Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...
Registry Participation 101: A Step-by-Step Guide to What You Really Need to K...
 
Clinical Healthcare Data Analytics
Clinical Healthcare Data AnalyticsClinical Healthcare Data Analytics
Clinical Healthcare Data Analytics
 
Understanding Digital Therapeutics: Journey into Imagination
Understanding Digital Therapeutics: Journey into ImaginationUnderstanding Digital Therapeutics: Journey into Imagination
Understanding Digital Therapeutics: Journey into Imagination
 
iHT² Health IT Summit Fort Lauderdale 2013 – Neal Ganguly, Vice President and...
iHT² Health IT Summit Fort Lauderdale 2013 – Neal Ganguly, Vice President and...iHT² Health IT Summit Fort Lauderdale 2013 – Neal Ganguly, Vice President and...
iHT² Health IT Summit Fort Lauderdale 2013 – Neal Ganguly, Vice President and...
 
Presentation 1.0
Presentation 1.0Presentation 1.0
Presentation 1.0
 
Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...
Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...
Real-World Evidence Studies_ Introduction, Purpose, and Data Collection Strat...
 
Big Data Provides Opportunities, Challenges and a Better Future in Health and...
Big Data Provides Opportunities, Challenges and a Better Future in Health and...Big Data Provides Opportunities, Challenges and a Better Future in Health and...
Big Data Provides Opportunities, Challenges and a Better Future in Health and...
 
Case Study "Using Real Time Clinical Data To Support Patient Risk Stratificat...
Case Study "Using Real Time Clinical Data To Support Patient Risk Stratificat...Case Study "Using Real Time Clinical Data To Support Patient Risk Stratificat...
Case Study "Using Real Time Clinical Data To Support Patient Risk Stratificat...
 
IMS Health RWES: The Future of Real-World Insights in Cancer
IMS Health RWES: The Future of Real-World Insights in CancerIMS Health RWES: The Future of Real-World Insights in Cancer
IMS Health RWES: The Future of Real-World Insights in Cancer
 
Services for Healthcare Industry - ScienceSoft
Services for Healthcare Industry - ScienceSoftServices for Healthcare Industry - ScienceSoft
Services for Healthcare Industry - ScienceSoft
 
McGrath Health Data Analyst SXSW
McGrath Health Data Analyst SXSWMcGrath Health Data Analyst SXSW
McGrath Health Data Analyst SXSW
 
How Pharma Can Use Digital Health to Drive Value | A Medullan Webinar
How Pharma Can Use Digital Health to Drive Value | A Medullan WebinarHow Pharma Can Use Digital Health to Drive Value | A Medullan Webinar
How Pharma Can Use Digital Health to Drive Value | A Medullan Webinar
 
PPT on Vigiflow, Argus-G and Aris For ADR Reporting
PPT on Vigiflow, Argus-G and Aris For ADR ReportingPPT on Vigiflow, Argus-G and Aris For ADR Reporting
PPT on Vigiflow, Argus-G and Aris For ADR Reporting
 
Healthcare Analytics Adoption Model
Healthcare Analytics Adoption ModelHealthcare Analytics Adoption Model
Healthcare Analytics Adoption Model
 

Mais de Kevin Lee

Introduction of AWS Cloud Computing and its future for Biometric Department
Introduction of AWS Cloud Computing and its future for Biometric DepartmentIntroduction of AWS Cloud Computing and its future for Biometric Department
Introduction of AWS Cloud Computing and its future for Biometric Department
Kevin Lee
 
A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...
A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...
A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...
Kevin Lee
 
Prompt it, not Google it - Prompt Engineering for Data Scientists
Prompt it, not Google it - Prompt Engineering for Data ScientistsPrompt it, not Google it - Prompt Engineering for Data Scientists
Prompt it, not Google it - Prompt Engineering for Data Scientists
Kevin Lee
 
Leading into the Unknown? Yes, we need Change Management Leadership
Leading into the Unknown? Yes, we need Change Management LeadershipLeading into the Unknown? Yes, we need Change Management Leadership
Leading into the Unknown? Yes, we need Change Management Leadership
Kevin Lee
 
Perfect partnership - machine learning and CDISC standard data
Perfect partnership - machine learning and CDISC standard dataPerfect partnership - machine learning and CDISC standard data
Perfect partnership - machine learning and CDISC standard data
Kevin Lee
 
Machine Learning : why we should know and how it works
Machine Learning : why we should know and how it worksMachine Learning : why we should know and how it works
Machine Learning : why we should know and how it works
Kevin Lee
 
End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...
End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...
End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...
Kevin Lee
 
Are you ready for Dec 17, 2016 - CDISC compliant data?
Are you ready for Dec 17, 2016 - CDISC compliant data?Are you ready for Dec 17, 2016 - CDISC compliant data?
Are you ready for Dec 17, 2016 - CDISC compliant data?
Kevin Lee
 
SAS integration with NoSQL data
SAS integration with NoSQL dataSAS integration with NoSQL data
SAS integration with NoSQL data
Kevin Lee
 
Introduction of semantic technology for SAS programmers
Introduction of semantic technology for SAS programmersIntroduction of semantic technology for SAS programmers
Introduction of semantic technology for SAS programmers
Kevin Lee
 

Mais de Kevin Lee (20)

Introduction of AWS Cloud Computing and its future for Biometric Department
Introduction of AWS Cloud Computing and its future for Biometric DepartmentIntroduction of AWS Cloud Computing and its future for Biometric Department
Introduction of AWS Cloud Computing and its future for Biometric Department
 
A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...
A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...
A fear of missing out and a fear of messing up : A Strategic Roadmap for Chat...
 
Prompt it, not Google it - Prompt Engineering for Data Scientists
Prompt it, not Google it - Prompt Engineering for Data ScientistsPrompt it, not Google it - Prompt Engineering for Data Scientists
Prompt it, not Google it - Prompt Engineering for Data Scientists
 
Leading into the Unknown? Yes, we need Change Management Leadership
Leading into the Unknown? Yes, we need Change Management LeadershipLeading into the Unknown? Yes, we need Change Management Leadership
Leading into the Unknown? Yes, we need Change Management Leadership
 
How to create SDTM DM.xpt using Python v1.1
How to create SDTM DM.xpt using Python v1.1How to create SDTM DM.xpt using Python v1.1
How to create SDTM DM.xpt using Python v1.1
 
Enterprise-level Transition from SAS to Open-source Programming for the whole...
Enterprise-level Transition from SAS to Open-source Programming for the whole...Enterprise-level Transition from SAS to Open-source Programming for the whole...
Enterprise-level Transition from SAS to Open-source Programming for the whole...
 
How I became ML Engineer
How I became ML Engineer How I became ML Engineer
How I became ML Engineer
 
Artificial Intelligence in Pharmaceutical Industry
Artificial Intelligence in Pharmaceutical IndustryArtificial Intelligence in Pharmaceutical Industry
Artificial Intelligence in Pharmaceutical Industry
 
Tell stories with jupyter notebook
Tell stories with jupyter notebookTell stories with jupyter notebook
Tell stories with jupyter notebook
 
Perfect partnership - machine learning and CDISC standard data
Perfect partnership - machine learning and CDISC standard dataPerfect partnership - machine learning and CDISC standard data
Perfect partnership - machine learning and CDISC standard data
 
Machine Learning : why we should know and how it works
Machine Learning : why we should know and how it worksMachine Learning : why we should know and how it works
Machine Learning : why we should know and how it works
 
Big data for SAS programmers
Big data for SAS programmersBig data for SAS programmers
Big data for SAS programmers
 
Big data in pharmaceutical industry
Big data in pharmaceutical industryBig data in pharmaceutical industry
Big data in pharmaceutical industry
 
How FDA will reject non compliant electronic submission
How FDA will reject non compliant electronic submissionHow FDA will reject non compliant electronic submission
How FDA will reject non compliant electronic submission
 
End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...
End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...
End to end standards driven oncology study (solid tumor, Immunotherapy, Leuke...
 
Are you ready for Dec 17, 2016 - CDISC compliant data?
Are you ready for Dec 17, 2016 - CDISC compliant data?Are you ready for Dec 17, 2016 - CDISC compliant data?
Are you ready for Dec 17, 2016 - CDISC compliant data?
 
SAS integration with NoSQL data
SAS integration with NoSQL dataSAS integration with NoSQL data
SAS integration with NoSQL data
 
Introduction of semantic technology for SAS programmers
Introduction of semantic technology for SAS programmersIntroduction of semantic technology for SAS programmers
Introduction of semantic technology for SAS programmers
 
Standards Metadata Management (system)
Standards Metadata Management (system)Standards Metadata Management (system)
Standards Metadata Management (system)
 
Data centric SDLC for automated clinical data development
Data centric SDLC for automated clinical data developmentData centric SDLC for automated clinical data development
Data centric SDLC for automated clinical data development
 

Último

Search and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical FuturesSearch and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical Futures
Bhaskar Mitra
 

Último (20)

From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
 
Search and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical FuturesSearch and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical Futures
 
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
 
Connector Corner: Automate dynamic content and events by pushing a button
Connector Corner: Automate dynamic content and events by pushing a buttonConnector Corner: Automate dynamic content and events by pushing a button
Connector Corner: Automate dynamic content and events by pushing a button
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
 
Exploring UiPath Orchestrator API: updates and limits in 2024 🚀
Exploring UiPath Orchestrator API: updates and limits in 2024 🚀Exploring UiPath Orchestrator API: updates and limits in 2024 🚀
Exploring UiPath Orchestrator API: updates and limits in 2024 🚀
 
Powerful Start- the Key to Project Success, Barbara Laskowska
Powerful Start- the Key to Project Success, Barbara LaskowskaPowerful Start- the Key to Project Success, Barbara Laskowska
Powerful Start- the Key to Project Success, Barbara Laskowska
 
UiPath Test Automation using UiPath Test Suite series, part 2
UiPath Test Automation using UiPath Test Suite series, part 2UiPath Test Automation using UiPath Test Suite series, part 2
UiPath Test Automation using UiPath Test Suite series, part 2
 
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 
UiPath Test Automation using UiPath Test Suite series, part 1
UiPath Test Automation using UiPath Test Suite series, part 1UiPath Test Automation using UiPath Test Suite series, part 1
UiPath Test Automation using UiPath Test Suite series, part 1
 
Optimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through ObservabilityOptimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through Observability
 
AI revolution and Salesforce, Jiří Karpíšek
AI revolution and Salesforce, Jiří KarpíšekAI revolution and Salesforce, Jiří Karpíšek
AI revolution and Salesforce, Jiří Karpíšek
 
SOQL 201 for Admins & Developers: Slice & Dice Your Org’s Data With Aggregate...
SOQL 201 for Admins & Developers: Slice & Dice Your Org’s Data With Aggregate...SOQL 201 for Admins & Developers: Slice & Dice Your Org’s Data With Aggregate...
SOQL 201 for Admins & Developers: Slice & Dice Your Org’s Data With Aggregate...
 
Unpacking Value Delivery - Agile Oxford Meetup - May 2024.pptx
Unpacking Value Delivery - Agile Oxford Meetup - May 2024.pptxUnpacking Value Delivery - Agile Oxford Meetup - May 2024.pptx
Unpacking Value Delivery - Agile Oxford Meetup - May 2024.pptx
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
 

Patient’s Journey using Real World Data and its Advanced Analytics

  • 1. Patient’s Journey using RealWorld Data and itsAdvancedAnalytics Kevin Lee
  • 2. Disclaimer The views and opinions presented here represent those of the speaker and should not be considered to represent any companies or organizations.
  • 3. • What is RWD? • Why is it important? • Patient’s Journey using RWD • Examples of Insights from RWD • Challenges in RWD • Technology requirements of RWD • Conclusion
  • 4. 4 What is Real Word Data (RWD)? Data collected outside of Clinical Trial Study Real World Data Clinical Trial Data
  • 5. 5 The Examples of Real Word Data (RWD) RWD Electronic Health Records (EHR) (e.g., Optum Market Clarity Data) Claim Activities (e.g., IQVIA LAAD, NPA, Xponent, LRx) Billing Activities (e.g., Insurance Payer data) Patient Registry
  • 6. 6 Real World Data vs Clinical Trial Data Real World Data Clinical Trial Data Population All the population Population of Eligible Criteria Patients Number ~100 million 300 to 3,000 volunteers in Phase 3 Bias Various bias Minimized bias Environment Real World Controlled Visit Any Visit Scheduled Visit Purpose Effectiveness Efficacy Treatment Schedule As needed Fixed Comparison All the drugs Placebo / Control Patient Monitor As needed Continuous during Clinical Trial Data Quality As they come Cleaned Data Collection Various sources (e.g., EHR, Claims) EDC per protocol Data Format Any format SAS dataset format Data Structure Any data structure Tabular data structure
  • 7. 7 Why is RWD important? • More comprehensive, holistic patient journey history • More Personalized medicine • Safety and Efficacy findings in bigger population • More complete pictures on how medicines are used in the real world rather than controlled environment in Clinical Trial • Leading to better clinical trial design (e.g., Patient recruitment, other indication ) • Helping drug companies to manage product life cycle (pre-launch, post- launch, during patent, after patent) • Helping drug companies for marketing and sales strategies
  • 8. 8 Patient 1001 got AC1 LAB test on 2020- 01-15. Patient 1001 started “Metformin ” on 2020- 01-25. Patient 1001 was diagnosed with ‘prediabetes’ on 2020-01-22. Patient 1001 got AC1 LAB test on 2021- 01-10. Patient 1001 was diagnosed with ‘Diabetes, Type 2’ on 2021-01-20. Patient 1001 switched to “Jardiance 10 mg” on 2021-01-23. Patient 1001 got AC1 LAB test on 2021- 06-14. Patient 1001 switched to “Jardiance 25 mg” on 2021-06-20. Patient 1001 visited his family doctor. Patient 1001 used “Aetna” insurance Patient 1001 complained about “Dizziness”. Patient 1001 got AC1 lab result at 6.2% on 2020-01-21 Patient 1001 got AC1 lab result at 7.1% on 2021-01-18 Patient 1001 got AC1 lab result at 8.0% on 2021-06-18 Patient 1001 got AC1 LAB test on 2022- 01-14. Patient 1001 got AC1 lab result at 7.0% on 2022-01-18 Patient’s Journey in RWD
  • 9. 9 Data in RWD Patient’s Journey Real World Data (RWD) Patient Demograp hics Diagnosis Procedures Claims Healthcare Provider Insurance Payers AE LAB Vital • EHR • Patient’s Medical Activity based • Demo, Vitals, Lab, AE, provider’s notes • Claims • Patient’s Claim Activity based • Prescriptions, Diagnosis, Procedures • Source • Providers • Payers
  • 10. 10 Examples of insights from RWD (1) Clinical Trial Optimization • Originally, Jardiance is approved for Type 2 Diabetes treatment, but in RWD, it has been prescribed for pre-diabetes patients. • Using RWD, Statisticians / programmers has found Jardiance show positive effectiveness with low safety issues. • Using RWD, Statisticians / programmers could compare effectiveness compared to competitors. • Using RWD, Statisticians / programmers could find safety information of medicines. • Using RWD, Patients recruitments are more effective.
  • 11. 11 Sales Performance Metrics • Geographic Sales Performance • Sales Performance vs Forecasts • Sales Comparison with Competitors ( e.g., 50% market share for Jardiance) • Sales Performance by quarters or month • Source of Business • New • Switch • Continued Examples of insights from RWD (2)
  • 12. 12 Sales Performance Metrics GeographicSales Performance Sales Performance vs Forecasts Sales Comparison with Competitors Sales Performance by quarters Source of Business New Switch Continued Examples of insights from RWD (3) Treatment Effectiveness / Personalized Medicine • 1st Line vs 2nd Line • Combo and Mono Therapy • Patient Profile – Age, Gender, Races, Diagnosis
  • 13. 13 Challenge in RWD • Quality of data • As they come, not cleaned / validated • High possibility of Bias • Various data sources (e.g., Veeva CRM, IQVIA Claim, Hospital Data) • Unstructured / Unstandardized Data • Big Data • Data integration / ETL • System Infrastructure for RWD – Data Storage, Data Processing, Analysis • Return of Investment • Usage in Clinical Trials • Regulatory restriction
  • 15. RWD is Big Data • It contains up to 5 years of ~100 million patient’s records per TA. • ~1 trillion claims for Diagnosis, Procedure & Prescription. • Typical Analysis for RWD contain up to ~1 trillion records. • Tools : Cloud Computing
  • 16. RWD in Cloud Computing • Big Data in RWD requires much bigger computing power, which fits well with Cloud Computing. • Flexible and scalable Cloud Computing environment will serve RWD Advanced Analytics (e.g. AI, prediction, Data Visualization) well. • An easy access for the reports and analysis thru internet connection. • A great collaboration environment / platform for research and analysis. • Tools : AWS, Azure, Databricks
  • 17. RWD in Central Database / Data Warehouse 17 • Tool to store, manage and govern RWD Data • Security and Data Quality for Sensitive health care data • Data Share and Access to different stakeholders • Centralized data storage • Tool : AWS Redshift, Snowflake, Oracle, Hive
  • 18. RWD in Open-Source Programming • RWD is not a regulatory required data. • Open-source programming for advanced analytics (e.g. Machine Learning, Data Visualization) • More and more organizations are expanding to open- source programming for RWD analysis for operating cost and advanced analysis. • Tool : R, Python, SQL, R-Shiny
  • 19. RWD in Data Visualization • Monthly and weekly performance metrics of the products in market • Interactive dashboard implementation by filters and graphs • Patients Journey from Diagnosis, EHR, to Prescriptions • Tool : Tableau, Power BI 19
  • 20. RWD in Machine Learning/ Prediction 20 • Predicting the treatment effectiveness • Clinical Trial Optimization on Study Design, Patients recruitments • Drug Discovery on identifying potential drug targets • Predicting personalized Medicine for patients • Structured data from unstructured data ( e.g., Insights from doctors’ notes) • Tools : Jupyter, R Studio, Databricks, Machine Learning, Deep Learning, Natural Language Procession, Convolutional Neural Network
  • 21. 21 Conclusion • Real World Data could provide valuable medical and business(commercial) insight and understanding in Real World Situation. • RWD could bring comprehensive, holistic real world patient’s journey history (e.g., up to 5 years or more ), leading to Personalized Medicine. • RWD could support drug pipelines (e.g., clinical trials) and commercial drug management (e.g., marketing and sales). • More and more RWD will be integrated with Biometric function. • RWD need technology investment (e.g., Big Data, Cloud Computing, Open- Source, Machine Learning) to fully utilize its potential and benefits.